Aducanumab and adenoviral COVID-19 vaccines: increased cerebral hemorrhage risk?

The abstract was removed and reincorporated into the main body of the text. (Since Editorial articles within the expert collection journals no longer include abstracts.).

[1]  S. Pavord,et al.  VITT and Second Doses of Covid-19 Vaccine. , 2021, The New England journal of medicine.

[2]  A. Charidimou,et al.  Vessels Sing Their ARIAs: The Role of Vascular Amyloid in the Age of Aducanumab , 2021, Stroke.

[3]  F. Barkhof,et al.  Amyloid-Related Imaging Abnormalities in 2 Phase 3 Studies Evaluating Aducanumab in Patients With Early Alzheimer Disease , 2021, JAMA neurology.

[4]  A. Alavi,et al.  Aducanumab (Marketed as Aduhelm) Approval Is Likely Based on Misinterpretation of PET Imaging Data. , 2021, Journal of Alzheimer's disease : JAD.

[5]  Thalia Shoshana Field,et al.  Characteristics and Outcomes of Patients With Cerebral Venous Sinus Thrombosis in SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia. , 2021, JAMA neurology.

[6]  K. Khunti,et al.  Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and SARS-CoV-2 positive testing: self-controlled case series study , 2021, BMJ.

[7]  G. Ambler,et al.  Clinical Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis , 2021, The New England journal of medicine.

[8]  M. Bahmanyar,et al.  Vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis post COVID-19 vaccination; a systematic review , 2021, Journal of the Neurological Sciences.

[9]  J. Mayerle,et al.  Anti–platelet factor 4 antibodies causing VITT do not cross-react with SARS-CoV-2 spike protein , 2021, Blood.

[10]  John D Lambris,et al.  Is complement the culprit behind COVID-19 vaccine-related adverse reactions? , 2021, The Journal of clinical investigation.

[11]  Andreas Greinacher,et al.  Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination , 2021, The New England journal of medicine.

[12]  Adam P. Silverman,et al.  APOE immunotherapy reduces cerebral amyloid angiopathy and amyloid plaques while improving cerebrovascular function , 2021, Science Translational Medicine.

[13]  R. Sperling,et al.  Cerebral amyloid angiopathy and Alzheimer disease — one peptide, two pathways , 2019, Nature Reviews Neurology.

[14]  C. Humpel,et al.  Platelets isolated from an Alzheimer mouse damage healthy cortical vessels and cause inflammation in an organotypic ex vivo brain slice model , 2018, Scientific Reports.

[15]  David A Hartmann,et al.  Rodent Models of Cerebral Microinfarct and Microhemorrhage. , 2018, Stroke.

[16]  A. Park,et al.  CENTER FOR DRUG EVALUATION AND RESEARCH , 2009 .

[17]  Urso FORTE. Urso.  HIGHLIGHTS OF PRESCRIBING INFORMATION , 2007 .

[18]  I. Ferrer,et al.  Neuropathology and Pathogenesis of Encephalitis following Amyloid β Immunization in Alzheimer's Disease , 2004, Brain pathology.